Insider · CIK 0001611024

Chang David D

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001611024

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-16	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−47.8K sh	$2.47	−$118K	5,150,599
2026-02-02	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−95.3K sh	$1.80	−$171K	5,185,862
2026-02-02	ALLOAllogene Therapeutics, Inc. · Restricted Stock UnitA Award	Director, President and CEO	AAward	+393K sh	—	—	392,586
2026-02-02	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, President and CEO	AAward	+1.39M sh	—	—	1,387,931
2025-03-14	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−46.7K sh	$1.96	−$91.5K	5,276,569
2025-02-03	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−46K sh	$1.68	−$77.3K	5,317,237
2025-01-24	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+552K sh	—	—	5,363,240
2025-01-24	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, President and CEO	AAward	+1.95M sh	—	—	1,952,130
2024-05-16	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+345K sh	$2.90	+$1M	4,810,106
2024-03-14	ALLOAllogene Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−53.4K sh	$4.33	−$231K	4,465,278
2024-01-25	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+318K sh	—	—	4,513,203
2024-01-25	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, President and CEO	AAward	+1.12M sh	—	—	1,123,535
2023-03-22	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.49M sh	—	—	1,492,200
2023-03-22	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+1.92M sh	—	—	4,193,911
2023-03-14	ALLOAllogene Therapeutics, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−22.3K sh	$5.56	−$124K	2,269,447
2022-03-23	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+2.2M sh	—	—	2,195,512
2022-03-15	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−23.6K sh	$7.65	−$181K	2,289,652
2021-05-24	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−27.4K sh	—	—	541,190
2021-05-24	ALLOAllogene Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.4K sh	$18.22	+$499K	2,312,279
2021-03-26	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+80.5K sh	—	—	2,284,869
2021-03-26	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+299K sh	—	—	298,836
2021-03-15	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−20.5K sh	$38.57	−$791K	2,204,417
2020-08-31	ALLOAllogene Therapeutics, Inc.G Gift	Director, President and CEO	GGift	+206K sh	—	—	856,044
2020-08-31	ALLOAllogene Therapeutics, Inc.G Gift	Director, President and CEO	GGift	+206K sh	—	—	856,044
2020-04-24	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,187 sh	—	—	2,224,101
2020-04-24	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,198 sh	—	—	1,201,108
2020-03-18	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+569K sh	—	—	568,600
2020-03-18	ALLOAllogene Therapeutics, Inc.G Gift	Director, President and CEO	GGift	+428K sh	—	—	650,266
2020-03-18	ALLOAllogene Therapeutics, Inc.G Gift	Director, President and CEO	GGift	+428K sh	—	—	650,266
2020-03-16	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−18.7K sh	$19.24	−$360K	2,215,426
2020-03-16	ALLOAllogene Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,625 sh	$20.06	−$32.6K	2,214,914
2020-03-04	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,234,136
2020-03-04	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,191,910
2019-11-19	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,182,508
2019-11-19	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,224,745
2019-10-25	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,173,106
2019-10-25	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,215,354
2019-09-23	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,163,704
2019-09-23	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,205,963
2019-09-05	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,195,469
2019-09-05	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,154,302
2019-07-18	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,402 sh	—	—	1,144,900
2019-07-18	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+9,391 sh	—	—	2,186,078
2019-07-10	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+6,388 sh	—	—	2,176,687
2019-06-18	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+10.2K sh	—	—	1,135,498
2019-05-13	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+11.8K sh	—	—	1,125,344
2019-04-26	ALLOAllogene Therapeutics, Inc.J Other	Director, President and CEO	JOther	+11.8K sh	—	—	1,113,591
2019-03-13	ALLOAllogene Therapeutics, Inc.A Award	Director, President and CEO	AAward	+173K sh	—	—	2,168,625
2019-03-13	ALLOAllogene Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+293K sh	—	—	292,700
2018-10-15	ALLOAllogene Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director, President and CEO	CConversion	−5,704 sh	—	—	0

Recent filings

Accepted (ET)
Mar 184
Chang David D0001737287-26-000013
SEC(opens sec.gov)
Feb 44
Chang David D0001737287-26-000009
SEC(opens sec.gov)
Mar 184
Chang David D0001737287-25-000042
SEC(opens sec.gov)
Feb 54
Chang David D0001737287-25-000017
SEC(opens sec.gov)
Jan 284
Chang David D0001737287-25-000004
SEC(opens sec.gov)
May 204
Chang David D0001593968-24-000714
SEC(opens sec.gov)
Mar 184
Chang David D0001593968-24-000477
SEC(opens sec.gov)
Jan 314
Chang David D0001593968-24-000192
SEC(opens sec.gov)
Mar 244
Chang David D0001593968-23-000521
SEC(opens sec.gov)
Mar 164
Chang David D0001737287-23-000025
SEC(opens sec.gov)
Mar 254
Chang David D0001214659-22-004374
SEC(opens sec.gov)
Mar 174
Chang David D0001214659-22-004085
SEC(opens sec.gov)
May 264
Chang David D0001214659-21-005927
SEC(opens sec.gov)
Apr 24/A
Chang David D0001214659-21-003892
SEC(opens sec.gov)

Companies

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080